Obesity and risk for salivary gland tumors

Obesity and Cancer Research

Volumn , Issue , 2009, Pages 71-85

  Suba, Zsuzsaanna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875325074     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (75)

1. Agarwall GB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7: 93-124, 1996
2. Anderos GL, Judd HL, Kaunitz AM et al. Womens’s Health Intitative Investigator Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic producers: The Women’s Health Intitative randomised trial. JAMA 290: 1739-1748, 2003
3. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O’Sullian MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S. Women’s Health Intitative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Intitiative randomized controlled trial. JAMA 291: 1701-1712, 2004
4. Barnes-Josiah D, Potter JD, Sellers TA, Himes JH: Early body-size and subsequent weight-gain as predictors of breast-cancer incidence (Iowa, United-States) Cancer Causes & Control 6(2) 112-118, 1995
5. Berclaz G, Li S, Price KN et al. Body mass index as a prognostic feature in operable breast cancer: The International Breast Cancer Study Group experience. Ann Oncol 15: 875-884, 2004
6. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 3: 565-574, 2002
7. Björntorp P. Obesity. Lancet 350: 423-426, 1997
8. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591, 2004
9. Calle EE, Miraclemcmahill HL, Thun MJ, Heath CW: Estrogen replacement therapy and risk of fatal colon-cancer in a prospective cohort of postmenopausal women. Journal Of The National Cancer Institute 87 (7) 517-523, 1995
10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348: 1625-1638, 2003
11. Calle EE, Thun JT. Obesity and cancer. Oncogene 23: 6365-6378, 2004
12. Chlebowsky RT, Aiello E, McTiernan A. Weight loss in breast cancer management. J Clin Oncol 20: 1128-1143, 2002
13. Chlebowsky RT. Obesity and early-stage breast cancer. J Clin Oncol 23: 1345-1347, 2005
14. Chow WH, Blot WJ, Vaughn TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. Journal Of The National Cancer Institute 90(2): 150-155, 1998
15. Chow WH, Gridley G, Fraumeni JF, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. New England Journal Of Medicine 343(18): 1305-1311, 2000
16. Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF. Obesity and risk of renal cell cancer. Cancer Epidemiology Biomarkers & Prevention 5(1): 17-21, 1996
17. Clandinin MT, Cheema CJ, Field ML, Garg J, Vendatraman J, Clandinin TR: Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5: 2761, 1991
18. Coates RJ, Clark WS, Eley JW, Greenberg RS, Huguley CM, Brown RL. race, nutritional-status, and survival from breast-cancer. Journal Of The National Cancer Institute 82(21): 1684-1692, 1990
19. Coleman H, Altini M, Nayler S, Richards A. Sialoadenosis: a presenting sign of bulimia. Head & Neck 20: 758-762, 1998
20. Enger SM, Greif JM, Polikoff J et al: Body weight correlates with mortality in early stage breast cancer. Arch Surg 139: 954-960. 2004
21. Facchini FS, Hua N, Abbasi F et al. Insulin resistance as a predictor of age related diseases. J Clin Endocrinol & Metab 86: 3574-3578, 2001
22. Fasshauer M, Paschke R. Regulation adipocytokines and insulin resistance. Diabetologia 46: 1594-1603, 2003
23. Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE: Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiology Biomarkers & Prevention 13(2) 220-224, 2004
24. Field CJ, Ryan EA, Thomson ABR, Clandinin MT: Diet fat composition alters membrane phospholipid composition, insulin binding and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 265: 43,1990
25. Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, Potter JD, Prineas RJ. Bodyfat distribution and 5-year risk of death in older women. JAMA-Journal Of The American Medical Association 269(10): 1254-1254, 1993
26. Giovannucci E, Ascherio A, Rimm E, Colditz GA, Stampfer MJ and Willett W. Phisical activity, obesity and risk for colon cancer and adenoma in women. Ann. Intern. Med. 122, 327-334, 1995
27. Hill HA, Austin H. Nutrition and endometrial cancer. Cancer Causes & Control 7(1): 19-32, 1996
28. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. New England Journal of Medicine 351(26): 2694-2703, 2004
29. Huang ZP, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC: Dual effects of weight and weight gain on breast cancer risk. JAMA-Journal Of The American Medical Association 278 17 1407-1411 NOV 5 1997
30. IARC Handbooks of Cancer Prevention. Weight control and physical activity. International Agency for Research on Cancer. Lyon. 2002
31. Ito K, Utsunomiya H, Yaegashi N, Sasano H: Biological roles of estrogen and progesterone in human endometrial carcinoma-new developments in potential endocrine therapy for endometrial cancer. Endocrine Journal 54: 667-679, 2007
32. Jee SH, Kim HJ, Lee J. Obesity, insulin resistance and cancer risk. Yonsei Med J. 46(4): 449-455, 2005
33. Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin MV. Dietary fat, genes and human health. Adv Experiment Med Biol 422: 167-176, 1997
34. Kaaks R, Lukanova A. Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. Ann N.Y. Acad Sci. 963: 268-281, 2002
35. Kaaks R, Van Noord PA, DenTonkelaar I, Peeters PJH, Riboli E and Grobbee DE. Breast cancer incidence in relation to height, weight and body fat distribution in the Dutch “DOM” cohort. Int. J. Cancer 76, 647-651, 1998
36. Key TJ, Applyby PN, Reeves GK. Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95: 1218-1226, 2003
37. Key TJA, Pike MC. The dose-effect relationship between “unopposed” estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57: 205-212, 1988
38. Kim YI: Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link? Nutr Rev 56: 275-279, 1998
39. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New England Journal Of Medicine 340(11): 825-831, 1999
40. Le Roith D. Insulin-like growth factors and cancer. N. Engl. J. Med. 336, 633-640, 1997
41. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42(1): 107-112, 1999
42. Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. International Journal of Cancer. 118(2): 458-466, 2006
43. Maehle BO, Tretli S. Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients. Breast Cancer Research And Treatment 41(2): 123-130, 1996
44. Manicardi V, Camellini L, Bellodi G. et al. Evidence for an association of high blood pressure and hyperinsulinemia in obese men. J Clin Endocrinol Metab 62: 1302-1304, 1986
45. Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami HO, Mantzoros C. IGF-I and IGF-II in relation to colorectal cancer. International Journal Of Cancer 83(1): 15-17, 1999
46. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH and Speizer FE. Body weight and mortality among women. N. Engl. J. Med. 333, 677-685, 1995
47. Mattison R, Jensen M. The adipocyte as an endocrine cell. Curr Opin Endocrinol Diabetes 10: 317-321, 2003
48. McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF: A population-based case control study of renal-cell carcinoma. Journal Of The National Cancer Institute 72(2): 275-284, 1984
49. Michels KB, Ekbom A: Caloric restriction and incidence of breast cancer. JAMA 291-1226-1230, 2004
50. Miller WR, O’Neill J. The importance of local synthesis of estrogen within the breast. Steroids 50: 537-548, 1987
51. Muti P, Quattrin T, Grant BJB et al. Fasting glucose is a risk factor for breast cancer. Cancer Epidemiol Biomark & Prev 11: 1361-1368, 2002
52. Nestler JE, Strauss JF. Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrin Metab Clin North Amer 20: 807-823, 1991
53. Pan SY, Johnson KC, Ugnat A-M, Wen SW, Mao Y, and the candidian Cancer Registries Epidemiology Research Group. Association of obesity and cancer risk in canada. American Journal of Epidemiology. 159(3): 259-268, 2004
54. Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes & Control 13(4): 325-332, 2002
55. Potischman N, Swanson C, Siiteri P and Hoover RN. Case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Canc. Inst. 88, 756-758, 1996
56. Rusotto SB. Asymptomatic parotid gland enlargement in diabetes mellitus. Oral Surg Oral Med Oral Pathol 52: 594-598, 1981
57. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R: Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA-Journal Of The American Medical Association 283(4) 485-491, 2000
58. Schneider JG, Tompkins C, Blumenthal RS, Mora S. The metabolic syndrome in women. Cardiol Rev 14: 286-291, 2006
59. Seidell J, Rissanen A: in Handbook of Obesity: Etiology and Pathophysiology (eds. Bray G, Bouchard C.) 93-107(Marcel Dekker, New York 2004).
60. Sheetz JH, Menaker L. Morphological and functional study of isoproterenol on salivary gland cells. Cell & Tissue Res 203: 321-329, 1979
61. Stattin P, Palmqvist R, Soderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Plasma leptin and colorectalcancer risk: a prospective study in Northern Sweden. Oncology Reports. 10(6): 2015-2021, 2003
62. Steinberg HO, Charker H, Leaming R et al. Obesity/insulin resistance is associated with endothel dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610, 1996
63. Stevens J, Plankey MW, Williamson DF, Thun MJ, Rust PF, Palesch Y and O’Neil PM. The body mass index-mortality relationship in white and African American women. Obesity 6, 268-277, 1998
64. Suba Zs, Barabás J, Szabó Gy, Takács D, Ujpál M: Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 28: 228, 2005
65. Suba Zs. Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res 13: 195-202, 2007
66. Suba Zs: Systemic risk factors for oral cancer: Estrogen deficiency and insulin resistance. Chapter 8. pp: 157-172 In: Progress in Oral Cancer Research. Ed: Frederik L. Nielsen, Nova Science Publishers, 2008
67. Suba Zs: Insulin resistance, estrogen deficiency and cancer risk. Chapter 7. In: Suba Zs: Estrogen versus cancer. In press, Nova Science Publishers, 2008
68. Tchernof A. Despres JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. [Review] Hormone & Metabolic Research. 32(11-12): 526-36, 2000
69. Tretli S, Haldorsen T, Ottestad L. The effect of premorbid height and weight on the survival of breast-cancer patients. British Journal Of Cancer 62(2): 299-303, 1990
70. Tsuji S, Kawai N, Tsuji M, Kawano S, Hori M. Review article. inflammation-related promotion of gastrointestinal carcinogenesis: a perigenetic pathway. Aliment Pharmacol Ther 18: 82-89, 2003
71. Wang Y, Jacobs EJ, Teras LR, Pavluck AL, Rodriguez C, Thun MJ, Calle EE. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women. Cancer Causes & Control. 18(8): 793-799, 2007
72. Weiderpass E, Gridley G, Persson I et al. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71: 360-363, 1997
73. Writing Group for the Women’s Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288, 321-333, 2002
74. Wu ShI, Chou P, Tsai ShT. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54: 117-120, 2001
75. Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG. Saliva and growth factors. J Dent Res 74: 1826-1832, 1995